Literature DB >> 18524773

FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness.

I-Ching Wang1, Yi-Ju Chen, Douglas E Hughes, Timothy Ackerson, Michael L Major, Vladimir V Kalinichenko, Robert H Costa, Pradip Raychaudhuri, Angela L Tyner, Lester F Lau.   

Abstract

The Forkhead box M1 (FoxM1) protein is a proliferation-specific transcription factor that plays a key role in controlling both the G(1)/S and G(2)/M transitions through the cell cycle and is essential for the development of various cancers. We show here that FoxM1 directly activates the transcription of the c-Jun N-terminal kinase (JNK1) gene in U2OS osteosarcoma cells. Expression of JNK1, which regulates the expression of genes important for the G(1)/S transition, rescues the G(1)/S but not the G(2)/M cell cycle block in FoxM1-deficient cells. Knockdown of either FoxM1 or JNK1 inhibits tumor cell migration, invasion, and anchorage-independent growth. However, expression of JNK1 in FoxM1-depleted cells does not rescue these defects, indicating that JNK1 is a necessary but insufficient downstream mediator of FoxM1 in these processes. Consistent with this interpretation, FoxM1 regulates the expression of the matrix metalloproteinases MMP-2 and MMP-9, which play a role in tumor cell invasion, through JNK1-independent and -dependent mechanisms in U2OS cells, respectively. Taken together, these findings identify JNK1 as a critical transcriptional target of FoxM1 that contributes to FoxM1-regulated cell cycle progression, tumor cell migration, invasiveness, and anchorage-independent growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524773      PMCID: PMC2475715          DOI: 10.1074/jbc.M709892200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.

Authors:  Galina A Gusarova; I-Ching Wang; Michael L Major; Vladimir V Kalinichenko; Timothy Ackerson; Vladimir Petrovic; Robert H Costa
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

2.  Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.

Authors:  B Dai; S-H Kang; W Gong; M Liu; K D Aldape; R Sawaya; S Huang
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

3.  The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.

Authors:  Yuichi Yoshida; I-Ching Wang; Helena M Yoder; Nicholas O Davidson; Robert H Costa
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

4.  Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.

Authors:  C Albanese; M D'Amico; A T Reutens; M Fu; G Watanabe; R J Lee; R N Kitsis; B Henglein; M Avantaggiati; K Somasundaram; B Thimmapaya; R G Pestell
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

5.  Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.

Authors:  Uma R Chandran; Changqing Ma; Rajiv Dhir; Michelle Bisceglia; Maureen Lyons-Weiler; Wenjing Liang; George Michalopoulos; Michael Becich; Federico A Monzon
Journal:  BMC Cancer       Date:  2007-04-12       Impact factor: 4.430

6.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

7.  FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

8.  c-Jun-deficient cells undergo premature senescence as a result of spontaneous DNA damage accumulation.

Authors:  Ann MacLaren; Elizabeth J Black; William Clark; David A F Gillespie
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Suppression of p53-dependent senescence by the JNK signal transduction pathway.

Authors:  Madhumita Das; Feng Jiang; Hayla K Sluss; Chao Zhang; Kevan M Shokat; Richard A Flavell; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

10.  Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.

Authors:  Zhiwei Wang; Sanjeev Banerjee; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

View more
  70 in total

Review 1.  Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.

Authors:  Tanya V Kalin; Vladimir Ustiyan; Vladimir V Kalinichenko
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

2.  Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2010-06-06       Impact factor: 4.742

3.  Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.

Authors:  Shahab Uddin; Maqbool Ahmed; Azhar Hussain; Jehad Abubaker; Nasser Al-Sanea; Alaa AbdulJabbar; Luai H Ashari; Samar Alhomoud; Fouad Al-Dayel; Zeenath Jehan; Prashant Bavi; Abdul K Siraj; Khawla S Al-Kuraya
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  FoxM1 is a novel target of a natural agent in pancreatic cancer.

Authors:  Zhiwei Wang; Aamir Ahmad; Sanjeev Banerjee; Asfar Azmi; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

5.  A model for the topology of active ribosomal RNA genes.

Authors:  Serguei Denissov; Frédéric Lessard; Christine Mayer; Victor Stefanovsky; Marc van Driel; Ingrid Grummt; Tom Moss; Hendrik G Stunnenberg
Journal:  EMBO Rep       Date:  2011-02-18       Impact factor: 8.807

6.  Steroid receptor co-activator-3 promotes osteosarcoma progression through up-regulation of FoxM1.

Authors:  Shuo Geng; Xiaoyu Wang; Xiaoyan Xu; Hepeng Zhang; Yan Ma; Yunqi Zhang; Baoxin Li; Zhenggang Bi; Chenglin Yang
Journal:  Tumour Biol       Date:  2013-11-27

7.  Forkhead box M1 transcriptional factor is required for smooth muscle cells during embryonic development of blood vessels and esophagus.

Authors:  Vladimir Ustiyan; I-Ching Wang; Xiaomeng Ren; Yufang Zhang; Jonathan Snyder; Yan Xu; Susan E Wert; James L Lessard; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Dev Biol       Date:  2009-10-14       Impact factor: 3.582

Review 8.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

9.  Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma.

Authors:  Jeffrey K Mito; Richard F Riedel; Leslie Dodd; Guy Lahat; Alexander J Lazar; Rebecca D Dodd; Lars Stangenberg; William C Eward; Francis J Hornicek; Sam S Yoon; Brian E Brigman; Tyler Jacks; Dina Lev; Sayan Mukherjee; David G Kirsch
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

10.  New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling.

Authors:  Laurent Schibler; Linda Gibbs; Catherine Benoist-Lasselin; Charles Decraene; Jelena Martinovic; Philippe Loget; Anne-Lise Delezoide; Marie Gonzales; Arnold Munnich; Jean-Philippe Jais; Laurence Legeai-Mallet
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.